📊 PETS Key Takeaways
Is Petmed Express Inc. (PETS) a Good Investment?
PETMED EXPRESS is in severe financial distress with a -39% net margin, negative operating cash flow of -$23.6M, and a critical liquidity crisis (0.89x current ratio). While modest YoY improvement in profitability shows some operational progress, the company remains deeply unprofitable with -$53M operating losses on $136M revenue, indicating fundamental business model challenges that threaten near-term viability.
Why Buy Petmed Express Inc. Stock? PETS Key Strengths
- No long-term debt minimizes financial leverage risk and restructuring complexity
- Net income and EPS improved 16-19% YoY demonstrating some operational progress toward profitability
- Gross margin of 26.6% proves core business model can be profitable with sufficient cost control or volume scaling
PETS Stock Risks: Petmed Express Inc. Investment Risks
- Deeply unprofitable with -39% net margin and -39% operating margin indicating structural business model challenges
- Negative operating cash flow of -$23.6M and free cash flow of -$27.5M mean company is burning capital at unsustainable rates
- Critical liquidity crisis with current ratio of 0.89x and only $26.9M cash reserves relative to $27.5M annual cash burn
Key Metrics to Watch
- Operating cash flow trajectory - must turn positive to demonstrate business viability
- Operating margin progression - needs material improvement from -39% baseline to reach breakeven
- Cash burn rate and runway - critical given minimal cash buffer relative to operating losses
Petmed Express Inc. (PETS) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
PETS Profit Margin, ROE & Profitability Analysis
PETS vs Consumer Sector: How Petmed Express Inc. Compares
How Petmed Express Inc. compares to Consumer sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Petmed Express Inc. Stock Overvalued? PETS Valuation Analysis 2026
Based on fundamental analysis, Petmed Express Inc. has mixed fundamental signals relative to the Consumer sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Petmed Express Inc. Balance Sheet: PETS Debt, Cash & Liquidity
PETS Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Petmed Express Inc.'s revenue has remained relatively flat over the 5-year period, with a 0% decline. The most recent EPS of $0.25 reflects profitable operations.
PETS Revenue Growth, EPS Growth & YoY Performance
PETS Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2026 | $40.7M | -$707.0K | $-0.03 |
| Q2 2026 | $44.4M | $2.3M | $0.11 |
| Q1 2026 | $51.2M | $3.8M | $0.18 |
| Q3 2025 | $53.0M | -$707.0K | $-0.03 |
| Q2 2025 | $59.6M | -$421.0K | $-0.02 |
| Q1 2025 | $68.0M | -$1.1M | $-0.06 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Petmed Express Inc. Dividends, Buybacks & Capital Allocation
PETS SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Petmed Express Inc. (CIK: 0001040130)
📋 Recent SEC Filings
❓ Frequently Asked Questions about PETS
What is the AI rating for PETS?
Petmed Express Inc. (PETS) has an AI rating of STRONG SELL with 88% confidence, based on fundamental analysis of SEC EDGAR filings.
What are PETS's key strengths?
Claude: No long-term debt minimizes financial leverage risk and restructuring complexity. Net income and EPS improved 16-19% YoY demonstrating some operational progress toward profitability.
What are the risks of investing in PETS?
Claude: Deeply unprofitable with -39% net margin and -39% operating margin indicating structural business model challenges. Negative operating cash flow of -$23.6M and free cash flow of -$27.5M mean company is burning capital at unsustainable rates.
What is PETS's revenue and growth?
Petmed Express Inc. reported revenue of $136.2M.
Does PETS pay dividends?
Petmed Express Inc. pays dividends, with $0.0M distributed to shareholders in the trailing twelve months.
Where can I find PETS SEC filings?
Official SEC filings for Petmed Express Inc. (CIK: 0001040130) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is PETS's EPS?
Petmed Express Inc. has a diluted EPS of $-2.55.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is PETS a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Petmed Express Inc. has a STRONG SELL rating with 88% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is PETS stock overvalued or undervalued?
Valuation metrics for PETS: ROE of -162.4% (sector avg: 18%), net margin of -39.1% (sector avg: 8%). Compare these metrics with sector averages to assess valuation.
Should I buy PETS stock in 2026?
Our dual AI analysis gives Petmed Express Inc. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is PETS's free cash flow?
Petmed Express Inc.'s operating cash flow is $-23.7M, with capital expenditures of $3.9M. FCF margin is -20.2%.
How does PETS compare to other Consumer stocks?
Vs Consumer sector averages: Net margin -39.1% (avg: 8%), ROE -162.4% (avg: 18%), current ratio 0.89 (avg: 1.5).